Literature DB >> 29111178

Dose-dependent neurocognitive deficits following postnatal day 10 HIV-1 viral protein exposure: Relationship to hippocampal anatomy parameters.

Sylvia Fitting1, Kristen A McLaurin2, Rosemarie M Booze2, Charles F Mactutus3.   

Abstract

Despite the availability of antiretroviral prophylactic treatment, pediatric human immunodeficiency virus type 1 (HIV-1) continues to be a significant risk factor in the post-cART era. The time of infection (i.e., during pregnancy, delivery or breastfeeding) may play a role in the development of neurocognitive deficits in pediatric HIV-1. HIV-1 viral protein exposure on postnatal day (P)1, preceding the postnatal brain growth spurt in rats, had deleterious effects on neurocognitive development and anatomical parameters of the hippocampus (Fitting et al., 2008a,b). In the present study, rats were stereotaxically injected with HIV-1 viral proteins, including Tat1-86 and gp120, on P10 to further examine the role of timing on neurocognitive development and anatomical parameters of the hippocampus (Fitting et al., 2010). The dose-dependent virotoxin effects observed across development following P10 Tat1-86 exposure were specific to spatial learning and absent from prepulse inhibition and locomotor activity. A relationship between alterations in spatial learning and/or memory and hippocampal anatomical parameters was noted. Specifically, the estimated number of neurons and astrocytes in the hilus of the dentate gyrus explained 70% of the variance of search behavior in Morris water maze acquisition training for adolescents and 65% of the variance for adults; a brain-behavior relationship consistent with observations following P1 viral protein exposure. Collectively, late viral protein exposure (P10) results in selective alterations in neurocognitive development without modifying measures of somatic growth, preattentive processing, or locomotor activity, as characterized by early viral protein exposure (P1). Thus, timing may be a critical factor in disease progression, with children infected with HIV earlier in life being more vulnerable to CNS disease.
Copyright © 2017 ISDN. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Gp120; Hippocampus; Pediatric HIV-1; Spatial learning; Stereology; Tat

Mesh:

Substances:

Year:  2017        PMID: 29111178      PMCID: PMC5889695          DOI: 10.1016/j.ijdevneu.2017.10.009

Source DB:  PubMed          Journal:  Int J Dev Neurosci        ISSN: 0736-5748            Impact factor:   2.457


  147 in total

1.  Evidence for developmental dopaminergic alterations in the human immunodeficiency virus-1 transgenic rat.

Authors:  Katy M Webb; Michael Y Aksenov; Charles F Mactutus; Rosemarie M Booze
Journal:  J Neurovirol       Date:  2010-03       Impact factor: 2.643

2.  HIV-1 Tat protein exits from cells via a leaderless secretory pathway and binds to extracellular matrix-associated heparan sulfate proteoglycans through its basic region.

Authors:  H C Chang; F Samaniego; B C Nair; L Buonaguro; B Ensoli
Journal:  AIDS       Date:  1997-10       Impact factor: 4.177

3.  Chronic over-expression of TGFβ1 alters hippocampal structure and causes learning deficits.

Authors:  Alonso Martinez-Canabal; Anne L Wheeler; Dani Sarkis; Jason P Lerch; Wei-Yang Lu; Marion S Buckwalter; Tony Wyss-Coray; Sheena A Josselyn; Paul W Frankland
Journal:  Hippocampus       Date:  2013-08-05       Impact factor: 3.899

4.  Early Antiretroviral Therapy in HIV-Infected Children Is Associated with Diffuse White Matter Structural Abnormality and Corpus Callosum Sparing.

Authors:  C Ackermann; S Andronikou; M G Saleh; B Laughton; A A Alhamud; A van der Kouwe; M Kidd; M F Cotton; E M Meintjes
Journal:  AJNR Am J Neuroradiol       Date:  2016-08-18       Impact factor: 3.825

5.  Measurement of CNS HIV burden and its association with neurologic damage.

Authors:  C A Wiley; E Masliah; C L Achim
Journal:  Adv Neuroimmunol       Date:  1994

6.  Low rates of mother-to-child transmission of HIV following effective pregnancy interventions in the United Kingdom and Ireland, 2000-2006.

Authors:  Claire L Townsend; Mario Cortina-Borja; Catherine S Peckham; Annemiek de Ruiter; Hermione Lyall; Pat A Tookey
Journal:  AIDS       Date:  2008-05-11       Impact factor: 4.177

7.  Dose-dependent long-term effects of Tat in the rat hippocampal formation: a design-based stereological study.

Authors:  Sylvia Fitting; Rosemarie M Booze; Ulla Hasselrot; Charles F Mactutus
Journal:  Hippocampus       Date:  2010-04       Impact factor: 3.899

8.  Impact on weight and height with the use of HAART in HIV-infected children.

Authors:  Sara Guillén; José Tomás Ramos; Rosa Resino; José María Bellón; María Angeles Muñoz
Journal:  Pediatr Infect Dis J       Date:  2007-04       Impact factor: 2.129

9.  Neurobehavioral Abnormalities in the HIV-1 Transgenic Rat Do Not Correspond to Neuronal Hypometabolism on 18F-FDG-PET.

Authors:  William C Reid; Rafael Casas; Georgios Z Papadakis; Siva Muthusamy; Dianne E Lee; Wael G Ibrahim; Anand Nair; Deloris Koziol; Dragan Maric; Dima A Hammoud
Journal:  PLoS One       Date:  2016-03-24       Impact factor: 3.240

Review 10.  Cognitive neuropsychology of HIV-associated neurocognitive disorders.

Authors:  Steven Paul Woods; David J Moore; Erica Weber; Igor Grant
Journal:  Neuropsychol Rev       Date:  2009-05-22       Impact factor: 7.444

View more
  2 in total

1.  S-EQUOL: a neuroprotective therapeutic for chronic neurocognitive impairments in pediatric HIV.

Authors:  Kristen A McLaurin; Hailong Li; Anna K Cook; Rosemarie M Booze; Charles F Mactutus
Journal:  J Neurovirol       Date:  2020-09-01       Impact factor: 2.643

Review 2.  Emerging Role of Nef in the Development of HIV Associated Neurological Disorders.

Authors:  Shadan S Yarandi; Michael R Duggan; Ilker K Sariyer
Journal:  J Neuroimmune Pharmacol       Date:  2020-10-29       Impact factor: 7.285

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.